Gene · 3191
Papers1,883
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,883
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immunosuppressive lncRNA LINC00624 promotes tumor progression and therapy resistance through ADAR1 stabilization. | J Immunother Cancer | 2022 | 36252997 | PubTator, text mining | PubMed |
| Identification of Prognostic LncRNAs Subtypes Predicts Prognosis and Immune Microenvironment for Glioma. | Evid Based Complement Alternat Med | 2022 | 36248415 | PubTator, text mining | PubMed |
| USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma. | Oncogene | 2022 | 36243803 | PubTator, text mining | PubMed |
| Implications of notch signaling in duchenne muscular dystrophy. | Front Physiol | 2022 | 36237531 | PubTator, text mining | PubMed |
| Construction and validation of a prognostic model with RNA binding protein-related mRNAs for the HBV-related hepatocellular carcinoma patients. | Front Oncol | 2022 | 36212461 | PubTator, text mining | PubMed |
| Expression profile of serum LncRNA THRIL and MiR-125b in inflammatory bowel disease. | PLoS One | 2022 | 36206229 | PubTator, text mining | PubMed |
| The solution structure of Dead End bound to AU-rich RNA reveals an unusual mode of tandem RRM-RNA recognition required for mRNA regulation. | Nat Commun | 2022 | 36202814 | PubTator, text mining | PubMed |
| Circular RNA circPVT1 promotes nasopharyngeal carcinoma metastasis via the β-TrCP/c-Myc/SRSF1 positive feedback loop. | Mol Cancer | 2022 | 36199071 | PubTator, text mining | PubMed |
| High expression of HNRNPR in ESCA combined with 18F-FDG PET/CT metabolic parameters are novel biomarkers for preoperative diagnosis of ESCA. | J Transl Med | 2022 | 36195940 | PubTator, text mining | PubMed |
| Epigenetic Regulation of Methylation in Determining the Fate of Dental Mesenchymal Stem Cells. | Stem Cells Int | 2022 | 36187229 | PubTator, text mining | PubMed |
| The transcriptome profile of RPE cells by the fullerenol against hydrogen peroxide stress. | Front Med (Lausanne) | 2022 | 36186803 | PubTator, text mining | PubMed |
| MBD5 and MBD6 stabilize the BAP1 complex and promote BAP1-dependent cancer. | Genome Biol | 2022 | 36180891 | PubTator, text mining | PubMed |
| Small-molecule screening identifies Syk kinase inhibition and rutaecarpine as modulators of macrophage training and SARS-CoV-2 infection. | Cell Rep | 2022 | 36179680 | PubTator, text mining | PubMed |
| Global circRNA expression changes predate clinical and histological improvements of psoriasis patients upon secukinumab treatment. | PLoS One | 2022 | 36174034 | PubTator, text mining | PubMed |
| FOXA1 regulates alternative splicing in prostate cancer. | Cell Rep | 2022 | 36170835 | PubTator, text mining | PubMed |
| ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold. | Theranostics | 2022 | 36168627 | PubTator, text mining | PubMed |
| Identification of the Regulatory Targets of miR-3687 and miR-4417 in Prostate Cancer Cells Using a Proteomics Approach. | Int J Mol Sci | 2022 | 36142477 | PubTator, text mining | PubMed |
| Diverse Roles of the Exon Junction Complex Factors in the Cell Cycle, Cancer, and Neurodevelopmental Disorders-Potential for Therapeutic Targeting. | Int J Mol Sci | 2022 | 36142288 | PubTator, text mining | PubMed |
| Systematic Analysis of Genetic and Pathway Determinants of Eribulin Sensitivity across 100 Human Cancer Cell Lines from the Cancer Cell Line Encyclopedia (CCLE). | Cancers (Basel) | 2022 | 36139690 | PubTator, text mining | PubMed |
| Promising Roles of Circular RNAs as Biomarkers and Targets for Potential Diagnosis and Therapy of Tuberculosis. | Biomolecules | 2022 | 36139074 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3191/papers?page=17